Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic acid plus hydrodistention versus hydrodistention alone for interstitial cystitis
IRCT20130811014330N5Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Cystistat in Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: urgency, frequency and 2 more. Started Apr 2017; status: completed.
02
Drugs
Cystistat
03
Conditions
Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS)
Beyond the preview
Go deeper on IRCT20130811014330N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130811014330N5.